Suppr超能文献

人血浆中硫酸皮肤素辅因子(肝素辅因子II)活性的测定。

Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.

作者信息

Abildgaard U, Larsen M L

出版信息

Thromb Res. 1984 Aug 1;35(3):257-66. doi: 10.1016/0049-3848(84)90357-8.

Abstract

An assay measuring the thrombin inactivating effect of human plasma in the presence of dermatan sulfate (DS) is described. Test plasma, diluted 1/50, is incubated with human thrombin in the presence of DS. Remaining thrombin is determined with chromogenic substrate 2AcOH . H-D-CHG-Ala-Arg-pNA. Three dilutions of reference plasma suffice and the standard curve is linear. Antithrombin III (AT) exerts a small (3-8%) effect in the assay. When test plasma contains heparin above 0.05 U/ml, this unspecific effect of AT increases, but it may be abolished by antibodies against AT. In a normal material (n = 50), the SD of DS cofactor activity was greater (15%) than that of AT (8.7%). DS cofactor was normal in hereditary AT deficiency and in 15 patients with deep venous thrombosis. In liver cirrhosis and in DIC, both inhibitors were markedly depressed, to similar degrees (r = 0.84).

摘要

本文描述了一种在硫酸皮肤素(DS)存在下测定人血浆凝血酶灭活作用的检测方法。将稀释50倍的待测血浆与DS一起与人凝血酶孵育。剩余的凝血酶用显色底物2AcOH.H-D-CHG-Ala-Arg-pNA进行测定。三种稀释度的参比血浆即可满足要求,且标准曲线呈线性。抗凝血酶III(AT)在该检测中发挥较小(3-8%)的作用。当待测血浆中肝素含量高于0.05 U/ml时,AT的这种非特异性作用会增强,但可通过抗AT抗体消除。在正常样本(n = 50)中,DS辅因子活性的标准差(15%)高于AT(8.7%)。在遗传性AT缺乏症患者及15例深静脉血栓形成患者中,DS辅因子正常。在肝硬化和弥散性血管内凝血(DIC)患者中,两种抑制剂均显著降低,且降低程度相似(r = 0.84)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验